Eastman Chemical (EMN) EBITDA Margin (2009 - 2026)

Eastman Chemical (EMN) has reported EBITDA Margin for 18 consecutive years, with 12.3% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA Margin rose 53.0% year-over-year to 12.3%; the trailing twelve-month figure through Jun 2026 stood at 8.46% (down 447.0% YoY), and the FY2025 full-year result was 9.54%, down 381.0% from the prior year.
• EBITDA Margin grew to 12.3% in Q2 2026 per EMN's latest filing, from 8.45% in the prior quarter.
• Across five years, EBITDA Margin topped out at 15.19% in Q2 2024 and bottomed at 3.4% in Q4 2025.
• Historically, EBITDA Margin has averaged 10.99% across 5 years, with a median of 11.69% in 2023.
• The sharpest annual moves came in 2023 and 2025: EBITDA Margin jumped 443 bps in 2023, then plunged 979 bps in 2025.
• Over 5 years, EBITDA Margin stood at 4.68% in 2022, then jumped by 95 bps to 9.11% in 2023, then soared by 45 bps to 13.18% in 2024, then sank by 74 bps to 3.4% in 2025, then surged by 262 bps to 12.3% in 2026.
• According to Business Quant data, EBITDA Margin over the past three periods registered 12.3%, 8.45%, and 3.4% for Q2 2026, Q1 2026, and Q4 2025 respectively.